- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04265560
Progressive Resistance Training in Acute Spinal Cord Injury
Progressive Resistance Training in Acute Spinal Cord Injury: a Pilot Randomised Controlled Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
The trial and recruitment will be conducted at the Queen Elizabeth National Spinal Injuries Unit (QENSIU), Glasgow. Individuals with tetraplegia and upper limb weakness will be randomly allocated to receive either a tailored progressive resistance training (PRT) programme alongside usual care or usual care alone.
Up to 30 participants admitted to the QENSIU will be recruited to the study. They will be randomised to the intervention or control group. The intervention group will receive 8 weeks of PRT. An upper limb functional goal will be identified through discussion with the researcher and the participant. PRT will be individually tailored to target two muscle groups which contribute to achieving this goal. For each muscle group 3 sets of 8-10 repetitions will be carried out, resistance will be applied using wrist weights, free weights or resistance bands as required. Measurements of muscle strength and function will be assessed prior to, and following the study. Outcome measures: Manual muscle testing, Handheld Dynamometry, The Spinal Cord Independence Measure, The Action Research Arm Test.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Glasgow, United Kingdom
- Queen Elizabeth University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Acquired non-progressive SCI - traumatic, spinal cord stroke, surgical injury
- Within 2 weeks of being identified as medically stable by the treating consultant
- Over 18 years old
- Individuals classified with complete or incomplete tetraplegia (C1-C8), graded A-D according to the American Spinal Injury Association (ASIA) scale
- Bilateral or unilateral partial paresis of at least two muscle groups of the upper limb
- Manual muscle testing grade 2-4 strength in target muscle groups
- Able to tolerate sitting upright in a wheelchair for at least 2 hours
Exclusion Criteria:
- Acute condition impairing a participant's ability to perform PRT (e.g. fracture)
- Proven or suspected neuromuscular weakness affecting the upper limbs due to another condition (e.g. stroke or Guillain-Barré syndrome)
- Unable to follow instructions in English
- Symptomatic cardiac disease
- Ventilator dependency
- Severe spasticity
- Uncontrolled autonomic dysreflexia
- Likely to be discharged before the end of the intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Progressive Resistance Training
The intervention group will receive 8 weeks of Progressive Resistance Training (PRT), twice a week, in addition to usual care. An upper limb functional goal will be identified through discussion with the researcher and the participant. PRT will be individually tailored to target two muscle groups and will be chosen in order to develop strength to progress towards the participants functional goal. The chronic spinal cord injury exercise guideline parameters will be applied (3 sets of 8-10 repetitions, 1-2 mins rest between sets). Participants will be inducted to their PRT programme and will then independently complete the 8 week programme. During each of the following sessions, assistance for set up of equipment and/or limb position will be given by the researcher and/or the participants family, friend or carer, once they have been trained. PRT sessions will be recorded in a diary to monitor sets and repetitions completed, and intensity (visual analogue scale (VAS)). |
Progressive resistance training programme for individuals following spinal cord injury.
|
|
No Intervention: Usual care only
Participants will continue with their usual care, consistent with standard National Health Service (NHS) care in this population.
Usual physiotherapy care is provided, up to 2 times per day, 4 to 5 days per week, each lasting up to 90 minutes.
Physiotherapists provide a combination of group exercise and one to one function-orientated physiotherapy sessions to improve balance, general muscle strength, wheelchair and/or transfer skills.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in muscular strength - handheld dynamometry
Time Frame: Baseline, 8 weeks
|
Muscular strength will be quantified using handheld dynamometry, the main upper limb muscle groups will be assessed, bilaterally. Shoulder flexors, extensors, abductors, adductors, lateral rotators, and medial rotators, elbow flexors and extensors, forearm pronators and supinators, and wrist flexors and extensors will be assessed. The order of testing the muscle groups will be consistent. Handheld dynamometry will be conducted implementing the 'make' test. The participant will exert a maximal force against the device whilst the assessor will maintain the position of the device. Three trials will be performed for each upper limb muscle group. Prevention of muscle fatigue will be achieved by a 30-second recovery after each trial and 2 minutes rest between muscle groups. One or 2 trials will be used to familiarise participants with the testing procedure. |
Baseline, 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Manual muscle testing
Time Frame: Baseline, 8 weeks
|
Muscular strength will be quantified using manual muscle testing, the main upper limb muscle groups will be assessed, bilaterally.
Shoulder flexors, extensors, abductors, adductors, lateral rotators, and medial rotators, elbow flexors and extensors, forearm pronators and supinators, and wrist flexors and extensors will be assessed.
The order of testing the muscle groups will be consistent.
Manual muscle testing using the Medical Research Council ordinal scale will be conducted once using standardised positions.
This scale ranges from 0 to 5, 0: no palpable or visible muscle contraction, up to 5: muscle can move against gravity and maximal resistance over full range of motion.
|
Baseline, 8 weeks
|
|
The Spinal Cord Independence Measure (SCIM III)
Time Frame: Baseline, 8 weeks
|
The Spinal Cord Independence Measure (SCIM III) is a measure of functional independence for individuals with SCI.
It is composed of 19 items that assesses 3 domains: self-care, respiration and sphincter management and mobility.
The total SCIM III scores range from 0 to 100.
0 represents total dependence, 100 represents complete independence.
The blind assessor will score participants on the items for each subscale.
The subscale 'self-care' exclusively relates to upper limb ability.
SCIM III reflects important aspects of independence specific to the SCI population.
Its use has been recommended for individuals with tetraplegia, changes within the self-care category relate to changes in upper limb function.
Furthermore, it has been reported to be reliable and valid for patients with traumatic SCI.
|
Baseline, 8 weeks
|
|
The Action Research Arm Test (ARAT)
Time Frame: Baseline, 8 weeks
|
Upper limb function will be assessed using The Action Research Arm Test (ARAT) following the standardised protocol outlined by Yozbatiran et al., (2008).
The ARAT assesses participants ability to grasp, grip and pinch objects, and make gross motor movements.
Standardised materials are required including a box with wooden blocks, alloy tubes, cups, marbles etc. Score for the ARAT ranges from 0-57 points, 57 points represents the best possible performance.
|
Baseline, 8 weeks
|
|
Perception of ability
Time Frame: 8 weeks
|
At the end of the intervention period, each participant in the intervention group will be asked to rate if their functional goal has changed on a 15-point scale from -7 'a very great deal worse', to +7 'a very great deal better'.
|
8 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hannah Houliston, Glasgow Caledonian University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19/WS/0149
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Paralysis
-
Neurotrigger LtdRecruitingParalysis | Paralysis; Eye | Paralysis; BellIsrael
-
Assistance Publique - Hôpitaux de ParisCompletedUnilateral Diaphragmatic ParalysisFrance
-
Marmara UniversityNot yet recruitingHemidiaphragmatic Paralysis
-
Seoul National University HospitalCompleted
-
University Hospital, RouenUniversity Hospital, CaenCompleted
-
University of WashingtonCompletedResidual Paralysis, Post AnesthesiaUnited States
-
Lawson Health Research InstituteSuspended
-
University of MinnesotaCompleted
-
Ben-Gurion University of the NegevCompleted
-
Brigham and Women's HospitalCompletedPhrenic Nerve ParalysisUnited States
Clinical Trials on Progressive Resistance Training
-
Bangor UniversityBetsi Cadwaladr University Health BoardCompletedChronic Kidney DiseaseUnited Kingdom
-
Superior UniversityActive, not recruiting
-
Pamukkale UniversityCompletedTotal Knee ArthroplastyTurkey
-
Stian EllefsenSykehuset Innlandet HFCompleted
-
Kufa UniversityNot yet recruiting
-
National Geriatric HospitalRecruitingDiabetes | SarcopeniaVietnam
-
Beth Israel Deaconess Medical CenterCompleted
-
Herlev HospitalCompletedHead and Neck CancerDenmark
-
University of Illinois at ChicagoNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertension | Sarcopenia | High Blood PressureUnited States